RHEUMATOID ARTHRITIS ADVISOR

Rheumatoid Arthritis Advisor

Feature

Switch or Swap: Strategies for Anti-TNF Failure in Rheumatoid Arthritis

In patients with rheumatoid arthritis who have experienced treatment failure, switching to a second TNF inhibitor is generally successful, according to investigators.
Women With RA Should Be Closely Monitored Before and During Pregnancy

Investigators suggest vigilance and careful pregnancy planning by a team of obstetricians and rheumatologists to reduce obstetric complications in women with RA.
Nanotherapies for Rheumatoid Arthritis: Advantages, Challenges, and Future Direction

Christine Pham, MD, chief of the Division of Rheumatology at the Washington University School of Medicine in St Louis discusses the advantages and challenges of applying nanotherapies in rheumatoid arthritis.
A Deeper Look at RA Disease Activity and Sleep Quality

The study authors examined the association between rheumatoid arthritis disease activity and different dimensions of sleep quality.
Rheumatoid Arthritis Extra-Articular Manifestations: Challenges of Interstitial Lung Disease

The investigators summarize extra-articular manifestations in rheumatoid arthritis, emphasizing the recognized risk factors and the available guidelines to managing them and comorbidities in patients with rheumatoid arthritis.

News

Tapering bDMARD Treatment in RA Reduces Cost but Affects Quality of Life

Rheumatology Advisor Contributing Writer

January 17, 2020

Researchers found data that showed costs were reduced while tapering treatment with biologic disease-modifying antirheumatic drug therapies in patients with rheumatoid arthritis, but with a decrease in quality-adjusted life years.

Multifaceted Factors Influence Rheumatologists’ Prescribing Practices

Rheumatology Advisor Contributing Writer

January 16, 2020

Researchers interviewed rheumatologists in England to determine what factors they use to determine treatment in rheumatoid arthritis.

Manifestations of Inflammation and Pain Flares in Rheumatoid Arthritis

Hannah Dellabella

January 8, 2020

Investigators found data to determine subgroups of patients with rheumatoid arthritis, namely patients with DAS28 and pain flares, which they believe will help guide treatment.

New Biomarker May Predict DAS-Remission During Tocilizumab Therapy in RA

Rheumatology Advisor Contributing Writer

January 6, 2020

In patients with rheumatoid arthritis, serum levels of reactive oxygen metabolites during treatment with tocilizumab are indicative of future clinical remission.

Learning Collaborative Model Improves Treat-to-Target Documentation in RA

Hannah Dellabella

January 3, 2020

Investigators found data that showed that the documentation of a treat-to-target approach in rheumatoid arthritis was improved by a learning collaborative intervention with participation by rheumatologists and their patients.